强生Q2业绩超预期并上调全年指引，股价下跌
2026-07-16 00:09:23
据CNBC报道，强生（Johnson & Johnson）第二季度营收同比增长6.6%至253.1亿美元，高于市场预期的250.5亿美元；调整后每股收益2.90美元，亦超预期的2.85美元。公司上调全年业绩指引，预计运营收入增长6.5%-7.1%，调整后每股收益区间升至11.60-11.75美元。但强生股价周二下跌逾2%。首席财务官沃克（Joe Wolk）在CNBC采访中称，心血管业务未达公司标准，团队正着手解决，认为该问题属短期性质。制药业务运营收入增长6.8%，创新药板块表现强劲。公司重申买入评级，并将目标价从265美元上调至275美元。
Disclaimer:
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.
Previous article：
沪港通深港通持股：盈富基金增持最多 中石化减持居首
